Our Product Pipeline
More information about current and past clinical trials sponsored by MapLight is available on the official ClinicalTrials.gov website maintained by the US National Library of Medicine. When available, results and links to publications of clinical trial data will be made available on this site.
References
- Ropacki, S. A., & Jeste, D. V. (2005). Epidemiology of and risk factors for psychosis of Alzheimer’s disease: A review of 55 studies published from 1990 to 2003. American Journal of Psychiatry, 162(11), 2022–2030. https://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.162.11.2022
- Bakker, G., Vingerhoets, C., Boucherie, D., Caan, M., Bloemen, O., Eersels, J., Booij, J., & van Amelsvoort, T. (2018). Relationship between muscarinic M1 receptor binding and cognition in medication-free subjects with psychosis. NeuroImage: Clinical, 18, 713–719. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857491/
- Kane, J. M., Agid, O., Baldwin, M. L., Howes, O., Lindenmayer, J.-P., Marder, S., Olfson, M., Potkin, S. G., & Correll, C. U. (2019). Clinical guidance on the identification and management of treatment-resistant schizophrenia. Journal of Clinical Psychiatry, 80(2), 18ac12023. https://www.psychiatrist.com/jcp/clinical-guidance-on-treatment-resistant-schizophrenia/
- Dean, B., Bakker, G., Ueda, H. R., Tobin, A. B., Brown, A., & Kanaan, R. A. A. (2023). A growing understanding of the role of muscarinic receptors in the molecular pathology and treatment of schizophrenia. Frontiers in Cellular Neuroscience, 17, 1124333. https://doi.org/10.3389/fncel.2023.1124333
- Meyer, J. M., & Correll, C. U. (2023). Increased metabolic potential, efficacy, and safety of emerging treatments in schizophrenia. CNS Drugs, 37(7), 545–570. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374807/
- Yohn, C. N., Weiden, P. J., Felder, C. C., & Stahl, S. M. (2022). Muscarinic acetylcholine receptors for psychotic disorders: bench-side to clinic. Trends in Pharmacological Sciences. https://doi.org/10.1016/j.tips.2021.11.002
Recent Announcements
